Treatment of echinococcosis by plant extracts and traditional Chinese materia medica:research advances / 国际药学研究杂志

Echinococcosis(hydatid disease)is a global zoonotic parasitic disease. At present,surgery remains the preferred treatment for this disease,but there are problems such as incomplete treatment and secondary infection. Therefore,adjuvant therapy of drugs is also essential. Albendazole is considered to be one of the most effective drug,but it has many side effects. In contrast,botani- cals have fewer side effects,low cost,and high availability in the treatment of a wide range of diseases. Therefore,searching for herbs or plant extracts effectively treating echinococcosis has become an important topic. This paper summarizes the research progress in plant extracts and traditional Chinese materia medica in treatment of hydatid disease in vitro and in vivo,in order to provide reference for the treatment of echinococcosis by plant drugs.

Projection of Eye Disease Burden in Singapore

<p><b>INTRODUCTION</b>Singapore's ageing population is likely to see an increase in chronic eye conditions in the future. This study aimed to estimate the burden of eye diseases among resident Singaporeans stratified for age and ethnicity by 2040.</p><p><b>MATERIALS AND METHODS</b>Prevalence data on myopia, epiretinal membrane (ERM), retinal vein occlusion (RVO), age macular degeneration (AMD), diabetic retinopathy (DR), cataract, glaucoma and refractive error (RE) by age cohorts and educational attainment from the Singapore Epidemiology of Eye Diseases (SEED) study were applied to population estimates from the Singapore population model.</p><p><b>RESULTS</b>All eye conditions are projected to increase by 2040. Myopia and RE will remain the most prevalent condition, at 2.393 million (2.32 to 2.41 million) cases, representing a 58% increase from 2015. It is followed by cataract and ERM, with 1.33 million (1.31 to 1.35 million), representing an 81% increase, and 0.54 million (0.53 to 0.549 million) cases representing a 97% increase, respectively. Eye conditions that will see the greatest increase from 2015 to 2040 in the Chinese are: DR (112%), glaucoma (100%) and ERM (91.4%). For Malays, DR (154%), ERM (136%), and cataract (122%) cases are expected to increase the most while for Indians, ERM (112%), AMD (101%), and cataract (87%) are estimated to increase the most in the same period.</p><p><b>CONCLUSION</b>Results indicate that the burden for all eye diseases is expected to increase significantly into the future, but at different rates. These projections can facilitate the planning efforts of both policymakers and healthcare providers in the development and provision of infrastructure and resources to adequately meet the eye care needs of the population. By stratifying for age and ethnicity, high risk groups may be identified and targeted interventions may be implemented.</p>

Application of the domestic rebounder tonometer in children / 国际眼科杂志(Guoji Yanke Zazhi)

AlM:To evaluate the clinical application of the domestic rebound tonometer ( RBT ) in measuring intraocular pressure ( lOP) in healthy children. METHODS:lOP measurement was measured in bilateral eyes of 108 cases with domestic RBT. Then the lOP for the left eyes of the children older than 13 years was obtained with Goldmann applanation tonometry ( GAT) . RESULTS: Of the 108 children, 100 ( 92. 6%) had lOP measurement both eyes successfully. Of the 100 children, 24 were older than 13 years. The mean lOP values for the left eyes of the 24 children of RBT and GAT were (16. 0± 3. 0) mmHg (1kPa=7. 5mmHg) and (15. 7±2. 8) mmHg, respectively. There was no significant difference between the lOP of the two tonometers (P>0. 05). The lOP of RBT had a good liner relationship with that of GAT ( r=0. 849, P CONCLUSlON: Domestic RBT is a good instrument in detecting lOP in children and it seems to be very comfortable and easy when performing lOP measurement in children without an anesthetic.